4.7 Article

Differentiation between Radiation Necrosis and Tumor Progression Using Chemical Exchange Saturation Transfer

期刊

CLINICAL CANCER RESEARCH
卷 23, 期 14, 页码 3667-3675

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-16-2265

关键词

-

类别

资金

  1. Terry Fox Research Institute (TFRI) [1034]
  2. Canadian Cancer Society Research Institute [CCSRI 701640]

向作者/读者索取更多资源

Purpose: Stereotactic radiosurgery (SRS) is a common treatment used in patients with brain metastases and is associated with high rates of local control, however, at the risk of radiation necrosis. It is difficult to differentiate radiation necrosis from tumor progression using conventional MRI, making it a major diagnostic dilemma for practitioners. This prospective study investigated whether chemical exchange saturation transfer (CEST) was able to differentiate these two conditions. Experimental Design: Sixteen patients with brain metastases who had been previously treated with SRS were included. Average time between SRS and evaluation was 12.6 months. Lesion type was determined by pathology in 9 patients and the other 7 were clinically followed. CEST imaging was performed on a 3T Philips scanner and the following CEST metrics were measured: amide proton transfer (APT), magnetization transfer (MT), magnetization transfer ratio (MTR), and area under the curve for CEST peaks corresponding to amide and nuclear Overhauser effect (NOE). Results: Five lesions were classified as progressing tumor and 11 were classified as radiation necrosis (using histopathologic confirmation and radiographic follow-up). The best separation was obtained by NOEMTR (NOEMTR, necrosis = 8.9 +/- 0.9%, NOEMTR, progression = 12.6 +/- 1.6%, P < 0.0001) and Amide(MTR) (Amide(MTR, necrosis) = 8.2 +/- 1.0%, Amide(MTR, progression) = 12.0 +/- 1.9%, P < 0.0001). MT (MTnecrosis = 4.7 +/- 1.0%, MTprogression = 6.7 +/- 1.7%, P = 0.009) and NOEAUC (NOEAUC, necrosis = 4.3 +/- 2.0% Hz, NOEAUC, progression = 7.2 +/- 1.9% Hz, P = 0.019) provided statistically significant separation but with higher P values. Conclusions: CEST was capable of differentiating radiation necrosis from tumor progression in brain metastases. Both NOEMTR and Amide(MTR) provided statistically significant separation of the two cohorts. However, APT was unable to differentiate the two groups. (C) 2017 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据